ID   GRP1_RAT                Reviewed;         795 AA.
AC   Q9R1K8; O88469;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   29-MAY-2024, entry version 160.
DE   RecName: Full=RAS guanyl-releasing protein 1;
DE   AltName: Full=Calcium and DAG-regulated guanine nucleotide exchange factor II;
DE            Short=CalDAG-GEFII;
DE   AltName: Full=Ras guanyl-releasing protein;
GN   Name=Rasgrp1; Synonyms=Rasgrp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION AS RAS ACTIVATOR, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9789079; DOI=10.1073/pnas.95.22.13278;
RA   Kawasaki H., Springett G.M., Toki S., Canales J.J., Harlan P.,
RA   Blumenstiel J.P., Chen E.J., Bany I.A., Mochizuki N., Ashbacher A.,
RA   Matsuda M., Housman D.E., Graybiel A.M.;
RT   "A Rap guanine nucleotide exchange factor enriched highly in the basal
RT   ganglia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:13278-13283(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION AS RAS ACTIVATOR, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, INTERACTION WITH RAS, CALCIUM-BINDING, AND
RP   MUTAGENESIS OF 510-ASP--GLU-521.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9582122; DOI=10.1126/science.280.5366.1082;
RA   Ebinu J.O., Bottorff D.A., Chan E.Y.W., Stang S.L., Dunn R.J., Stone J.C.;
RT   "RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and
RT   diacylglycerol-binding motifs.";
RL   Science 280:1082-1086(1998).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=11279364; DOI=10.1023/a:1007245728751;
RA   Pierret P., Dunn R.J., Djordjevic B., Stone J.C., Richardson P.M.;
RT   "Distribution of ras guanyl releasing protein (RasGRP) mRNA in the adult
RT   rat central nervous system.";
RL   J. Neurocytol. 29:485-497(2000).
RN   [4]
RP   DIACYLGLYCEROL-BINDING.
RX   PubMed=10779365;
RA   Lorenzo P.S., Beheshti M., Pettit G.R., Stone J.C., Blumberg P.M.;
RT   "The guanine nucleotide exchange factor RasGRP is a high -affinity target
RT   for diacylglycerol and phorbol esters.";
RL   Mol. Pharmacol. 57:840-846(2000).
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=11738253; DOI=10.1016/s0306-4522(01)00429-8;
RA   Pierret P., Vallee A., Mechawar N., Dower N.A., Stone J.C.,
RA   Richardson P.M., Dunn R.J.;
RT   "Cellular and subcellular localization of Ras guanyl nucleotide-releasing
RT   protein in the rat hippocampus.";
RL   Neuroscience 108:381-390(2001).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12626538; DOI=10.4049/jimmunol.170.6.2877;
RA   Sanjuan M.A., Pradet-Balade B., Jones D.R., Martinez-A C., Stone J.C.,
RA   Garcia-Sanz J.A., Merida I.;
RT   "T cell activation in vivo targets diacylglycerol kinase alpha to the
RT   membrane: a novel mechanism for Ras attenuation.";
RL   J. Immunol. 170:2877-2883(2003).
RN   [7]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=15064353; DOI=10.1091/mbc.e03-11-0844;
RA   Carrasco S., Merida I.;
RT   "Diacylglycerol-dependent binding recruits PKCtheta and RasGRP1 C1 domains
RT   to specific subcellular localizations in living T lymphocytes.";
RL   Mol. Biol. Cell 15:2932-2942(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-597, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Functions as a calcium- and diacylglycerol (DAG)-regulated
CC       nucleotide exchange factor specifically activating Ras through the
CC       exchange of bound GDP for GTP (PubMed:9582122, PubMed:9789079).
CC       Activates the Erk/MAP kinase cascade. Regulates T-cell/B-cell
CC       development, homeostasis and differentiation by coupling T-
CC       lymphocyte/B-lymphocyte antigen receptors to Ras. Regulates NK cell
CC       cytotoxicity and ITAM-dependent cytokine production by activation of
CC       Ras-mediated ERK and JNK pathways (By similarity). Functions in mast
CC       cell degranulation and cytokine secretion, regulating FcERI-evoked
CC       allergic responses. May also function in differentiation of other cell
CC       types. Proto-oncogene, which promotes T-cell lymphomagenesis when its
CC       expression is deregulated (By similarity).
CC       {ECO:0000250|UniProtKB:O95267, ECO:0000250|UniProtKB:Q9Z1S3,
CC       ECO:0000269|PubMed:9582122, ECO:0000269|PubMed:9789079}.
CC   -!- ACTIVITY REGULATION: Autoinhibited (By similarity). Activated by
CC       diacylglycerol and calcium binding, which induces a conformational
CC       change releasing the autoinhibitory state (PubMed:9582122). Regulated
CC       by DGKA. Regulated by DGKZ. Regulated by PLC gamma and F-actin
CC       polymerization (By similarity). {ECO:0000250|UniProtKB:O95267,
CC       ECO:0000269|PubMed:9582122}.
CC   -!- SUBUNIT: Homodimer. Forms a signaling complex with DGKZ and HRAS.
CC       Interacts with F-actin. Interacts with SKAP1 (By similarity).
CC       {ECO:0000250|UniProtKB:O95267}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cell membrane; Peripheral
CC       membrane protein. Golgi apparatus membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}. Endoplasmic reticulum membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Found
CC       both in the cytosol and associated with membranes. Relocalization to
CC       the cell membrane upon activation is F-actin-dependent (By similarity).
CC       Translocates to the Golgi in response to phorbol ester or nerve growth
CC       factor (By similarity). Localizes to somata and dendrites but not to
CC       axons of hippocampal pyramidal cells. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Specifically expressed in brain with higher density
CC       in hippocampal CA1 and CA3 fields. Detected in interneurons and
CC       projection neurons with no restriction to any neuronal type or
CC       neurotransmitter phenotype but not detected in glial cells. Expressed
CC       in the hematopoietic system. Expressed in several neuronal types of the
CC       hippocampus and entorhinal cortex (at protein level).
CC       {ECO:0000269|PubMed:11279364, ECO:0000269|PubMed:11738253,
CC       ECO:0000269|PubMed:9789079}.
CC   -!- DEVELOPMENTAL STAGE: Expression appears in neurons of the hippocampus
CC       during the first 2 weeks after birth (at protein level).
CC       {ECO:0000269|PubMed:11738253}.
CC   -!- DOMAIN: The phorbol-ester/DAG-type zinc finger is the principal
CC       mediator of the targeting to membranes and is required for functional
CC       activation through DAG-binding.
CC   -!- DOMAIN: Two EF-hand domains are present. However, only EF-hand 1 (and
CC       not EF-hand 2) binds calcium. {ECO:0000250|UniProtKB:O95267}.
CC   -!- SIMILARITY: Belongs to the RASGRP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF081196; AAC79700.1; -; mRNA.
DR   EMBL; AF060819; AAC40137.1; -; mRNA.
DR   RefSeq; NP_062084.2; NM_019211.2.
DR   AlphaFoldDB; Q9R1K8; -.
DR   SMR; Q9R1K8; -.
DR   STRING; 10116.ENSRNOP00000007687; -.
DR   BindingDB; Q9R1K8; -.
DR   ChEMBL; CHEMBL3109; -.
DR   iPTMnet; Q9R1K8; -.
DR   PhosphoSitePlus; Q9R1K8; -.
DR   PaxDb; 10116-ENSRNOP00000007687; -.
DR   GeneID; 29434; -.
DR   KEGG; rno:29434; -.
DR   UCSC; RGD:3539; rat.
DR   AGR; RGD:3539; -.
DR   CTD; 10125; -.
DR   RGD; 3539; Rasgrp1.
DR   VEuPathDB; HostDB:ENSRNOG00000005404; -.
DR   eggNOG; KOG3417; Eukaryota.
DR   HOGENOM; CLU_019261_0_0_1; -.
DR   InParanoid; Q9R1K8; -.
DR   OrthoDB; 4260488at2759; -.
DR   PhylomeDB; Q9R1K8; -.
DR   TreeFam; TF312918; -.
DR   Reactome; R-RNO-1169092; Activation of RAS in B cells.
DR   Reactome; R-RNO-354192; Integrin signaling.
DR   Reactome; R-RNO-392517; Rap1 signalling.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   PRO; PR:Q9R1K8; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   Bgee; ENSRNOG00000005404; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; ISO:RGD.
DR   GO; GO:0019992; F:diacylglycerol binding; ISO:RGD.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0042113; P:B cell activation; ISO:RGD.
DR   GO; GO:0042100; P:B cell proliferation; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0002437; P:inflammatory response to antigenic stimulus; ISO:RGD.
DR   GO; GO:0043303; P:mast cell degranulation; ISO:RGD.
DR   GO; GO:0030101; P:natural killer cell activation; ISO:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0032816; P:positive regulation of natural killer cell activation; ISO:RGD.
DR   GO; GO:0032825; P:positive regulation of natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISO:RGD.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; IBA:GO_Central.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0051896; P:regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0032252; P:secretory granule localization; ISO:RGD.
DR   GO; GO:0042110; P:T cell activation; ISO:RGD.
DR   GO; GO:0042098; P:T cell proliferation; ISO:RGD.
DR   GO; GO:0047496; P:vesicle transport along microtubule; ISO:RGD.
DR   CDD; cd20860; C1_RASGRP1; 1.
DR   CDD; cd22290; cc_RasGRP1_C; 1.
DR   CDD; cd00051; EFh; 1.
DR   CDD; cd00155; RasGEF; 1.
DR   CDD; cd06224; REM; 1.
DR   Gene3D; 3.30.60.20; -; 1.
DR   Gene3D; 6.10.250.2730; -; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.10.840.10; Ras guanine-nucleotide exchange factors catalytic domain; 1.
DR   Gene3D; 1.20.870.10; Son of sevenless (SoS) protein Chain: S domain 1; 1.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR008937; Ras-like_GEF.
DR   InterPro; IPR000651; Ras-like_Gua-exchang_fac_N.
DR   InterPro; IPR023578; Ras_GEF_dom_sf.
DR   InterPro; IPR001895; RASGEF_cat_dom.
DR   InterPro; IPR036964; RASGEF_cat_dom_sf.
DR   PANTHER; PTHR23113; GUANINE NUCLEOTIDE EXCHANGE FACTOR; 1.
DR   PANTHER; PTHR23113:SF174; RAS GUANYL-RELEASING PROTEIN 1; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF13202; EF-hand_5; 1.
DR   Pfam; PF00617; RasGEF; 1.
DR   Pfam; PF00618; RasGEF_N; 1.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00054; EFh; 1.
DR   SMART; SM00147; RasGEF; 1.
DR   SMART; SM00229; RasGEFN; 1.
DR   SUPFAM; SSF57889; Cysteine-rich domain; 1.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF48366; Ras GEF; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS50009; RASGEF_CAT; 1.
DR   PROSITE; PS50212; RASGEF_NTER; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Coiled coil; Cytoplasm; Differentiation;
KW   Endoplasmic reticulum; Golgi apparatus;
KW   Guanine-nucleotide releasing factor; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN           1..795
FT                   /note="RAS guanyl-releasing protein 1"
FT                   /id="PRO_0000316980"
FT   DOMAIN          53..176
FT                   /note="N-terminal Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00135"
FT   DOMAIN          205..436
FT                   /note="Ras-GEF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00168"
FT   DOMAIN          470..505
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          506..532
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   ZN_FING         541..591
FT                   /note="Phorbol-ester/DAG-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          1..37
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          57..110
FT                   /note="Ras exchanger motif region; required for
FT                   transforming activity"
FT                   /evidence="ECO:0000250"
FT   REGION          686..694
FT                   /note="Suppress the PT region-mediated translocation to
FT                   plasma membrane"
FT                   /evidence="ECO:0000250"
FT   REGION          717..795
FT                   /note="PT region; mediates the BCR-dependent translocation
FT                   to plasma membrane"
FT                   /evidence="ECO:0000250"
FT   COILED          738..779
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        9..23
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         483
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         485
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         487
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         489
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         494
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT   MOD_RES         184
FT                   /note="Phosphothreonine; by PKC"
FT                   /evidence="ECO:0000250|UniProtKB:O95267"
FT   MOD_RES         597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         510..521
FT                   /note="DKDREGLISRDE->AKARAGLISRDA: Loss of calcium-
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:9582122"
FT   CONFLICT        24
FT                   /note="G -> A (in Ref. 2; AAC40137)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   795 AA;  90245 MW;  14CC12EBBC967C39 CRC64;
     MGTLGKAREA PRKPCHGSRA GPKGRLEAKS TNSPLPAQPS LAQITQFRMM VSLGHLAKGA
     SLDDLIDSCI QSFDADGNLC RSNQLLQVML TMHRIIISSA ELLQKLMNLY KDALEKNSPG
     ICLKICYFVR YWITEFWIMF KMDASLTSTM EEFQDLVKAN GEESHCHLID TTQINSRDWS
     RKLTQRIKSN TSKKRKVSLL FDHLEPEELS EHLTYLEFKS FRRISFSDYQ NYLVNSCVKE
     NPTMERSIAL CNGISQWVQL MVLSRPTPQL RAEVFIKFIH VAQKLHQLQN FNTLMAVIGG
     LCHSSISRLK ETSSHVPHEI NKVLGEMTEL LSSCRNYDNY RRAYGECTHF KIPILGVHLK
     DLISLYEAMP DYLEDGKVNV QKLLALYNHI NELVQLQDVA PPLDANKDLV HLLTLSLDLY
     YTEDEIYELS YAREPRNHRA PPLTPSKPPV VVDWASGVSP KPDPKTISKH VQRMVDSVFK
     NYDLDQDGYI SQEEFEKIAA SFPFSFCVMD KDREGLISRD EITAYFMRAS SIYSKLGLGF
     PHNFQETTYL KPTFCDNCAG FLWGVIKQGY RCKDCGMNCH KQCKDLVVFE CKKRSKSPAV
     STENISSVVP MSTLCPLGTK DLLHAPEEGS FIFQNGEVVD HSEESKDRTI MLLGVSSQKI
     SVRLKRTVAH KTTQTESFPW VGGEMPPGHF VLTSPRKSAQ GALYVHSPAS PCPSPALVRK
     RAFVKWENKE SLIKPKPELH LRLRTYQELE QEVNTLRADN DALKIQLKYA QKQIESLQLG
     KSNHVLAQMD HGDGT
//
